secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001522767-23-000009
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q4 revenue up 15.5% YoY to $35.8M; net income turns positive but EBITDA margin shrinks
--------------------------------------------------------------------------------

- Q4 revenue $35.8M (+15.5% YoY); full-year revenue $134.0M (+10.3% YoY).
- GAAP net income Q4 $4.8M vs loss of $6.4M in prior year; full-year net income $13.6M (+79% YoY).
- Non-GAAP adjusted EBITDA Q4 $4.5M (down 46% YoY); full-year $32.4M (down 24% YoY).
- GAAP gross margin Q4 44% vs 50% prior year; full year 48% vs 55%.
- CEO: positive cash flow from ops for third consecutive year; expects accelerated growth in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/mrmd-20230301.htm
  HTML page:      https://secwatch.observer/filing/0001522767-23-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer